Présentation de l'entreprise
Acadia Healthcare Company, Inc. operates within the healthcare sector, specifically focusing on the medical care facilities industry by providing behavioral healthcare services throughout the United States and Puerto Rico. The corporation owns and manages a portfolio of acute inpatient psychiatric facilities alongside specialty treatment centers that include residential recovery programs and dedicated eating disorder facilities. With a market capitalization of $2.43 billion and an annual revenue of $3.31 billion, the company demonstrates significant scale within the behavioral health infrastructure. This substantial market cap and revenue base indicate that Acadia functions as a major player capable of influencing regional healthcare delivery and maintaining a large operational footprint employing approximately 19,000 individuals. The organization's extensive network of facilities allows it to address a wide spectrum of behavioral health needs, reinforcing its position as a critical component of the national mental health system.
Santé financière
The company reported total revenue of $3.31 billion over the trailing twelve months, yet recorded a net income of -$1,102,771,968, creating a stark disparity that reveals a highly leveraged cost structure where expenses significantly outweigh profits. Despite the negative net income, the entity generated an EBITDA of $577.21 million, suggesting that while accounting losses are prevalent, operational cash generation before interest and taxes remains positive at the core business level. However, free cash flow stands at -$370,052,864, which indicates that the company is currently consuming cash reserves to fund its operations and capital expenditures rather than generating surplus liquidity. The gross margin is calculated at 41.5%, reflecting a substantial portion of revenue retained after direct costs, while the operating margin sits at 5.8% and the profit margin is a negative 33.3%. These margin figures collectively illustrate that high overhead costs, likely driven by debt servicing and facility maintenance, are eroding operating income before interest expenses further depress the bottom line. The balance sheet shows a cash position of $133.24 million against total debt of $2.65 billion, resulting in a debt-to-equity ratio of 124.03, which characterizes the company as heavily leveraged and reliant on future earnings or refinancing to meet obligations. Liquidity is supported by a current ratio of 1.55, indicating that current assets exceed current liabilities by a comfortable margin to cover short-term obligations. Return on equity is negative at -41.0% and return on assets is 4.2%, metrics that reveal management is currently destroying shareholder value through equity dilution or losses while utilizing the asset base to generate minimal positive returns on the total capital employed.
Évaluation de la valorisation
The valuation metrics present a complex picture with a trailing P/E ratio listed as N/A due to the lack of positive earnings, contrasting with a forward P/E of 15.70 that implies market expectations for future profitability recovery. The absence of a trailing P/E highlights the current unprofitability, whereas the forward multiple suggests analysts anticipate a significant turnaround in earnings trajectory over the coming fiscal periods. The price-to-book ratio is 1.22, indicating that the market values the company at a slight premium over its net asset value, which can be attributed to the intangible value of its facility network and future growth prospects despite current losses. Alternative valuation measures include a price-to-sales ratio of 0.73 and an EV/EBITDA of 8.90, metrics that suggest the stock is priced reasonably relative to its sales volume and adjusted earnings power, providing a basis for valuation independent of the current negative net income. The stock has traded between a 52-week low of $11.43 and a 52-week high of $30.17, with the current price trading below the 52-week high, reflecting recent market volatility. The beta of 0.71 indicates that the stock's price volatility is lower than the broader market, suggesting it may be less sensitive to general market fluctuations but carries specific sector risks.
Growth & Income
Revenue growth stands at 6.1% year-over-year, while earnings growth is N/A due to the negative net income, meaning earnings are not growing in the traditional sense but are currently in a contraction phase relative to profitability standards. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which signifies that the firm reinvests all available cash flow and retained earnings into operational improvements and debt reduction rather than returning capital to shareholders. This lack of dividend income combined with negative earnings growth underscores a growth-at-any-cost strategy where the company prioritizes expanding its behavioral health network over providing immediate income to investors. The overall growth and income profile is characterized by top-line expansion supported by a strong revenue growth rate, but it lacks current income generation through dividends or earnings accretion, relying entirely on potential future profitability improvements to justify its market valuation.